![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
欧洲免疫组织化学市场预测至 2028 年 - 按应用(诊断和药物检测)、产品(抗体、设备、试剂和试剂盒)和最终用户(医院和诊断实验室、研究机构等)划分的 COVID-19 影响和区域分析
市场介绍
欧洲是免疫组化第二大市场,英国、德国、法国、意大利、西班牙等欧洲是该地区市场的主要贡献者。德国在预测期内引领市场。近年来,德国的癌症病例急剧增加;例如,根据全球癌症观察站的数据,2020 年,男女、各年龄段的新发病例总数为 6,28,519 例,其中乳腺癌病例为 69 697 例(11.1%),乳腺癌病例为 67 959 例(10.8%)。前列腺癌、64 804 例(10.3%)肺癌、57 528 例(9.2%)结直肠癌、35 147 例(5.6%)膀胱癌和 333 384 例(53%)其他癌症。免疫组织化学广泛应用于癌症的诊断和治疗;因此,该国对免疫组织化学的需求正在增加。我国心血管疾病的患病率呈上升趋势。老年人口是心血管疾病患病率上升的主要原因。人口结构的变化给患者护理带来了重大挑战。随着人口老龄化的加剧,慢性病的数量也在稳步增长。与此同时,医疗保健行业的成本压力不断加大。正如马克斯·普朗克研究所 2019 年所述,该国大约 30-40% 的成年人患有高血压。发病率随着年龄的增长而增加,60岁以上的人更容易患CVD。 IHC在临床诊断领域越来越受欢迎,因为它用于诊断癌症、传染病、心血管疾病和自身免疫性疾病等慢性疾病。因此,慢性病患病率的不断上升预计将增加对免疫组化解决方案的需求,从而促进市场增长。
欧洲国家,尤其是法国,因COVID-19爆发而受到严重影响。冠状病毒免疫组织化学抗体是一种免疫学方法,可用于识别感染鸟类和哺乳动物的 RNA 病毒冠状病毒科成员。下面列出了针对几种冠状病毒株(例如 SARS-CoV-2、SARS-CoV、MERS 和其他非人类病原体(例如猫冠状病毒))表达的抗原的抗体。常见的冠状病毒抗体靶点包括核衣壳 (N) 和刺突糖蛋白 (S)。这些抗体适用于免疫组织化学应用。免疫组织化学分析显示检测到 SARS-CoV-2 冠状病毒核衣壳的差异表达水平并证明了抗体特异性。使用 SARS/SARS-CoV-2 冠状病毒 NP 单克隆抗体 (B46F)(货号 MA1-7404)对 SARS-CoV-2 冠状病毒 NP 进行免疫组织化学分析,显示感染 SARS-CoV-2 的人肺和胎盘组织中有显着染色与没有 SARS-CoV-2 的对照组织相比。来自英国和瑞典的研究人员最近使用极其灵敏的多重免疫组织化学来检查 COVID-19 患者和对照组出现神经系统症状的患者大脑周细胞中 ACE2 的表达。他们还使用空间免疫表型分析来评估 COVID-19 患者脑组织的炎症。
市场概况和动态
欧洲免疫组化市场预计将从2021年的6.3133亿美元增长到2028年的10.2227亿美元;预计 2021 年至 2028 年复合年增长率为 7.1%。传统的诊断测试通常在拥有昂贵设备的实验室中进行,并配备经过培训的人员负责执行测试。过去几十年来,诊断检测逐渐从中心实验室发展到靠近患者的检测场所。对免疫组织化学的需求不断增长,加上免疫学实验室工作人员的短缺,产生了对免疫组织化学自动化的需求。免疫组织化学 (IHC) 自动化提供了提高灵敏度水平、重现性和标准化的机会,并具有减少工作时间和节省试剂等优势。分析灵活性是免疫组织化学方案中所需的基本因素之一。 IHC 的自动化对于免疫组织化学技术的标准化做出了决定性的贡献。此外,它还有助于将16步手动方法简化为5步方法,有助于最大限度地减少工作人员数量。此外,自动化免疫组织化学确保了染色剂质量和排放的一致性,并提高了不同技术的标准化和优化。此外,凭借可靠、快速的结果,自动化可以更快地提供诊断测试结果,从而缩短住院时间,从而节省成本。因此,免疫组织化学 (IHC) 自动化带来的各种好处很可能会被接受,并成为未来几年欧洲市场的流行趋势之一。
关键细分市场
从产品来看,2020年抗体细分市场占据欧洲免疫组化市场最大份额。从应用来看,诊断细分市场占有较大市场份额2020 年欧洲免疫组织化学市场。此外,根据 2020 年最终用户计算,医院和诊断实验室细分市场在欧洲免疫组织化学市场中占有较大份额。
主要来源和公司列出
准备本欧洲免疫组织化学市场报告时提到的一些主要一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据数据库等。报告中列出的主要公司有 Abcam plc;安捷伦科技公司;生物SB;生物拉德实验室有限公司;细胞信号技术公司;丹纳赫; F. 霍夫曼拉罗什有限公司;默克公司;珀金埃尔默公司;和 THERMO FISHER SCIENTIFIC INC。
购买报告的理由强>
- 了解欧洲免疫组织化学市场格局,并确定最有可能保证丰厚回报的细分市场
- 通过了解不断变化的趋势,保持领先地位欧洲免疫组织化学市场的竞争格局
- 通过识别最有可能销售前景的细分市场,有效规划欧洲免疫组织化学市场的并购和合作伙伴交易
- 帮助从敏锐的洞察力中做出明智的业务决策并对欧洲免疫组化市场各个细分市场的市场表现进行综合分析
- 获取欧洲地区2021-2028年各个细分市场的市场收入预测。 ul>
- 设备
- 载玻片染色系统
- 组织微阵列系统
- 组织处理系统
- 载玻片扫描仪
- 其他设备
- 抗体
- 一抗
- 二抗
- 试剂
- 组织学染色
- 封闭和固定试剂
- 显色底物
- 固定试剂
- 稳定剂
- 有机溶剂
- 蛋白水解酶
- 稀释剂
- 试剂盒
- 诊断
- 癌症
- 传染病
- 自身免疫性疾病
- 糖尿病
- 肾病
- 其他
- 药物检测
- 医院和诊断实验室
- 研究机构
- 其他
- 英国
- 德国
- 法国
- 意大利
- 西班牙
- 欧洲其他地区
- li>
- Abcam plc
- 安捷伦Technologies, Inc.
- Bio SB
- BIO-RAD LABORATORIES INC.
- Cell Signaling Technology, Inc.
- 丹纳赫
- F. HOFFMANN-LA ROCHE LTD.
- MERCK KGaA
- PerkinElmer Inc.
- Thermo FISHER SCIENTIFIC INC.
欧洲免疫组化市场细分
欧洲免疫组织化学市场 - 副产品
欧洲免疫组织化学市场 - 按应用划分
欧洲免疫组织化学市场 - 最终用户
欧洲免疫组织化学市场 - 按国家/地区
欧洲免疫组织化学市场 - 公司简介
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Immunohistochemistry Market – By Product
1.3.2 Europe Immunohistochemistry Market – By Application
1.3.3 Europe Immunohistochemistry Market – By End User
1.3.4 Europe Immunohistochemistry Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Immunohistochemistry Market – Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Experts Opinion
5. Europe Immunohistochemistry Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidences of Chronic and Infectious Diseases
5.1.2 Growing R&D Investments by Biotechnology & Biopharmaceutical Companies
5.2 Key Market Restraints
5.2.1 Issues Related to Immunohistochemistry
5.3 Key Market Opportunities
5.3.1 Opportunities in Several Countries
5.4 Future Trends
5.4.1 Use of Automation in Immunohistochemistry
5.5 Impact Analysis
6. Immunohistochemistry Market – Europe Analysis
6.1 Europe Immunohistochemistry Market Revenue Forecast and Analysis
7. Europe Immunohistochemistry Market Analysis– By Product
7.1 Overview
7.2 Europe Immunohistochemistry Market, By Product 2021 & 2028 (%)
7.3 Antibodies
7.3.1 Overview
7.3.2 Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.3 Primary Antibodies
7.3.3.1 Overview
7.3.3.2 Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.4 Secondary Antibodies
7.3.4.1 Overview
7.3.4.2 Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Equipment Market
7.4.1 Overview
7.4.2 Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.3 Slide Staining Systems
7.4.3.1 Overview
7.4.3.2 Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.4 Tissue Microarrays
7.4.4.1 Overview
7.4.4.2 Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.5 Tissue Processing Systems
7.4.5.1 Overview
7.4.5.2 Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.6 Slide Scanners
7.4.6.1 Overview
7.4.6.2 Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.7 Other Equipments
7.4.7.1 Overview
7.4.7.2 Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5 Reagents Market
7.5.1 Overview
7.5.2 Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.3 Histological Stains
7.5.3.1 Overview
7.5.3.2 Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.4 Blocking Sera & Reagents Market
7.5.4.1 Overview
7.5.4.2 Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.5 Chromogenic Substrates Market
7.5.5.1 Overview
7.5.5.2 Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.6 Stabilizers
7.5.6.1 Overview
7.5.6.2 Stabilizers Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.7 Proteolytic Enzymes
7.5.7.1 Overview
7.5.7.2 Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.8 Organic Solvents
7.5.8.1 Overview
7.5.8.2 Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.9 Fixation Reagents
7.5.9.1 Overview
7.5.9.2 Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.10 Diluents
7.5.10.1 Overview
7.5.10.2 Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.6 Kits Market
7.6.1 Overview
7.6.2 Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
8. Europe Immunohistochemistry Market Analysis – By Application
8.1 Overview
8.2 Europe Immunohistochemistry Market Share by Application 2021 & 2028 (%)
8.3 Diagnostics
8.3.1 Overview
8.3.2 Diagnostics Market Revenue and Forecast to 2028 (US$ Mn)
8.3.3 Cancer
8.3.3.1 Overview
8.3.3.2 Cancer Market Revenue and Forecast to 2028 (US$ Mn)
8.3.4 Infectious Diseases
8.3.4.1 Overview
8.3.4.2 Infectious Diseases Market Revenue and Forecast to 2028 (US$ Mn)
8.3.5 Autoimmune Diseases
8.3.5.1 Overview
8.3.5.2 Autoimmune Diseases Market Revenue and Forecast to 2028 (US$ Mn)
8.3.6 Diabetes Mellitus
8.3.6.1 Overview
8.3.6.2 Diabetes Mellitus Market Revenue and Forecast to 2028 (US$ Mn)
8.3.7 Nephrological Diseases
8.3.7.1 Overview
8.3.7.2 Nephrological Diseases Market Revenue and Forecast to 2028 (US$ Mn)
8.3.8 Others
8.3.8.1 Overview
8.3.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Drug Testing
8.4.1 Overview
8.4.2 Drug Testing Market Revenue and Forecast to 2028 (US$ Mn)
9. Europe Immunohistochemistry Market Analysis– By End User
9.1 Overview
9.2 Europe Immunohistochemistry Market, By End User 2021 & 2028 (%)
9.3 Hospital & Diagnostic Laboratories
9.3.1 Overview
9.3.2 Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
9.4 Research Institutes
9.4.1 Overview
9.4.2 Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
9.5 Others
9.5.1 Overview
9.5.2 Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10. Europe Immunohistochemistry Market – Country Analysis
10.1 Europe: Immunohistochemistry Market Revenue and Forecasts to 2028
10.1.1 Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)
10.1.1.1 UK Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.1.1 UK Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.1.2 UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.1.1.2.1 UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
10.1.1.1.2.2 UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.1.1.2.3 UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.1.1.1.3 UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
10.1.1.1.3.1 UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.1.1.1.4 UK Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
10.1.1.2 Germany Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.2.1 Germany Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.2.2 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.1.2.2.1 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
10.1.1.2.2.2 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.1.2.2.3 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.1.1.2.3 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
10.1.1.2.3.1 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.1.1.2.4 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
10.1.1.3 France Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.3.1 France Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.3.2 France Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.1.3.2.1 France Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
10.1.1.3.2.2 France Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.1.3.2.3 France Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.1.1.3.3 France Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
10.1.1.3.3.1 France Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.1.1.3.4 France Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
10.1.1.4 Italy Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.4.1 Italy Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.4.2 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.1.4.2.1 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
10.1.1.4.2.2 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.1.4.2.3 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.1.1.4.3 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
10.1.1.4.3.1 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.1.1.4.4 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
10.1.1.5 Spain Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.5.1 Spain Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.5.2 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.1.5.2.1 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
10.1.1.5.2.2 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.1.5.2.3 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.1.1.5.3 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
10.1.1.5.3.1 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.1.1.5.4 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
10.1.1.6 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.6.1 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.6.2 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.1.6.2.1 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
10.1.1.6.2.2 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.1.6.2.3 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.1.1.6.3 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
10.1.1.6.3.1 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.1.1.6.4 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
11. Impact Of COVID-19 Pandemic on Europe Immunohistochemistry Market
11.1 Europe: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic developments
12.3.1 Overview
13. Company Profiles
13.1 Cell Signaling Technology, Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 F. HOFFMANN-LA ROCHE LTD.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 MERCK KGaA
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 PerkinElmer Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 THERMO FISHER SCIENTIFIC INC.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Abcam plc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Agilent Technologies, Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 BIO-RAD LABORATORIES INC.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Danaher
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Bio SB
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)
Table 2. UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 3. UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 4. UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 5. UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 6. UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
Table 7. UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 8. UK Immunohistochemistry Market Revenue and Forecasts to 2028, by End User US$ Mn)
Table 9. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 10. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 11. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 12. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 13. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
Table 14. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 15. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by End User US$ Mn)
Table 16. France Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 17. France Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 18. France Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 19. France Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 20. France Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
Table 21. France Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 22. France Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
Table 23. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 24. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 25. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 26. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 27. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
Table 28. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 29. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
Table 30. Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 31. Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 32. Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 33. Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 34. Spain Immunohistochemistry Market Revenue and Forecast to 2028, by Application (USD Million)
Table 35. Spain Immunohistochemistry Market Revenue and Forecast to 2028, by Diagnostics (USD Million)
Table 36. Spain Immunohistochemistry Market Revenue and Forecast to 2028, by End User (USD Million)
Table 37. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 38. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 39. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 40. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 41. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
Table 42. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 43. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
Table 44. Organic Developments Done By Companies
Table 45. Inorganic developments done by Companies
Table 46. Glossary of Terms
LIST OF FIGURES
Figure 1. Europe Immunohistochemistry Market Segmentation
Figure 2. Europe Immunohistochemistry Market Segmentation, By Country
Figure 3. Europe Immunohistochemistry Market Overview
Figure 4. Antibodies Segment Held the Largest Share of the Market in 2021
Figure 5. The UK to Show Significant Growth During Forecast Period
Figure 6. Europe and PEST Analysis
Figure 7. Impact Analysis of Drivers and Restraints Pertaining to Europe Immunohistochemistry Market
Figure 8. Europe Immunohistochemistry Market – Revenue Forecast and Analysis
Figure 9. Europe Immunohistochemistry Market, by Product 2021 & 2028 (%)
Figure 10. Europe Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. Europe Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. Europe Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. Europe Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. Europe Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. Europe Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 16. Europe Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. Europe Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. Europe Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 19. Europe Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. Europe Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. Europe Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. Europe Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. Europe Stabilizer: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. Europe Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. Europe Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. Europe Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 27. Europe Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 28. Europe Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 29. Europe Immunohistochemistry Market Share by Application 2021 & 2028 (%)
Figure 30. Europe Diagnostics Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 31. Europe Cancer Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 32. Europe Infectious Diseases Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 33. Europe Autoimmune Diseases Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 34. Europe Diabetes mellitus Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 35. Europe Nephrological Diseases Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 36. Europe Others Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 37. Europe Drug Testing Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 38. Europe Immunohistochemistry Market, by End User 2021 & 2028 (%)
Figure 39. Europe Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 40. Europe Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 41. Europe Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 42. Europe: Immunohistochemistry Market Revenue Overview, by Country, 2021 (US$ MN)
Figure 43. Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)
Figure 44. UK Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 45. Germany Immunohistochemistry Products Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 46. France Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 47. Italy Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 48. Spain Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 49. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 50. Impact of COVID-19 Pandemic in European Country Markets
- Abcam plc
- Agilent Technologies, Inc.
- Bio SB
- BIO-RAD LABORATORIES INC.
- Cell Signaling Technology, Inc.
- Danaher
- F. HOFFMANN-LA ROCHE LTD.
- MERCK KGaA
- PerkinElmer Inc.
- THERMO FISHER SCIENTIFIC INC.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe immunohistochemistry market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Europe immunohistochemistry market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the immunohistochemistry market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution